Current Edition

Europe

Alector announces initiation of Phase 1 trial of AL001 for treating frontotemporal dementia

Alector, a privately held biotechnology company pioneering immuno-neurology, a novel therapeutic approach for the treatment of neurodegeneration, today announced the ...
Continue Reading →
news

Novel clinical trial to examine cannabis as potential treatment for essential tremor

Researchers at University of California School of Medicine are preparing to launch a novel clinical trial to examine the safety, efficacy and pharmacological properti...
Continue Reading →
MEANA Region

Resveratrol decreases pain severity and levels of inflammatory biomarkers in osteoarthritis patients

In what researchers state is the first pilot clinical trial to assess the effects of resveratrol on pain severity and levels of inflammatory biomarkers in patients wi...
Continue Reading →
Europe

Landmark MS trial launches in UK

  The biggest ever trial for secondary progressive multiple sclerosis (SPMS) has kicked off in the UK at around 30 sites in England, Scotland, Wales, Northern I...
Continue Reading →
Europe

The Lancet Respiratory Medicine publishes first Phase III trial for PT010 triple combination therapy in moderate to very severe chronic obstructive pulmonary disease

AstraZeneca today announced publication of results from the KRONOS Phase III trial which evaluated the efficacy and safety of triple combination therapy PT010 (budeso...
Continue Reading →
Australasia

Study finds daily aspirin does not reduce heart attack risk

Daily, low dose asprin found to not minimise heart attack risk. Monash University in Australia has repo...
Continue Reading →
Europe

Positive Phase 3 results presented for Dupixent® (dupilumab) show significant improvement on multiple measures of disease severity in adolescents with moderate-to-severe atopic dermatitis

Results on skin clearing, itch and certain quality of life measurements were presented today as a late-breaking oral presentation at the 27th EADV Congress   Par...
Continue Reading →
Europe

Alzheimer’s disease: amyloid β protein once again in the spotlight as a therapeutic target

World Alzheimer's Day on 21 September 2018 (Vienna, 18 September 2018) For many years amyloid β protein was considered to be a promising therapeutic target in Alz...
Continue Reading →
Europe

Persons with Alzheimer’s disease are more often hospitalized after initiating antibiotic use

Persons with Alzheimer’s disease (AD) are more often hospitalized after antibiotic initiation than people without AD, a new study from the University of Eastern Finla...
Continue Reading →
Asia Pacific

GamaMabs Pharma starts a phase 2 study of monoclonal antibody GM102 in patients with advanced or metastatic colorectal cancer

C201 phase 2 will study immuno-enhancer antibody GM102, targeting AMHRII as a single agent and in combination with Trifluridine/Tipiracil (Lonsurf®) Paris and Toulou...
Continue Reading →